Key facts
- This page summarizes Eric Curtis's Form 4 filing for WINDTREE THERAPEUTICS INC /DE/ (WINT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Mar 2022, 16:48.
Eric Curtis - 04 Mar 2022 Form 4 Insider Report for WINDTREE THERAPEUTICS INC /DE/ (WINT)
- Reporting relationship
- SVP & COO
- Issuer ticker
- WINT
- Reported as of
- 04 Mar 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Mar 2022, 16:48:59 UTC
- Next SEC filing
- 02 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John P. Hamill, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Curtis filed Form 4 for WINDTREE THERAPEUTICS INC /DE/ (WINT) on 07 Mar 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
WINT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +66,300
- Change %
- +5136%
- Price
- $0.000000
- Shares after
- 67,591
- Date
- 04 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
WINT
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +99,600
- Change %
- Price
- $0.000000
- Shares after
- 99,600
- Date
- 04 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 99,600
- Exercise price
- $1.02
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on February 28, 2023 provided that the reporting person remains in continuous service on each vesting date.
Footnote F2
This employee stock option shall vest and become exercisable with respect to one-twelfth of the total number of shares subject to the options on a quarterly basis (every three months) with the first vest date on May 31, 2022 provided that the reporting person remains in continuous service on each vesting date.